Subsequently, CD4+IL-10+ T cells were shown to exert immunosuppressive effects in various disease models, such as inflammatory bowel disease (IBD) and experimental autoimmune encephalomyelitis (EAE) [4, 5]. Here, IL10 is linked to inflammatory bowel disease.